SCHEMBL24033716

SCHEMBL24033716

Cc1nc(-c2cccc(CNC3CC3)c2)c(CO)nc1-c1cccc(Cl)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 5/20 0.45
▸ KCNH2 Q12809 2/20 0.41
▸ EGFR P00533 1/20 0.41
▸ SUV39H2 Q9H5I1 2/20 0.37
▸ ACHE P22303 1/20 0.37
▸ BACE1 P56817 1/20 0.37
▸ DHODH Q02127 1/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ NMT1 P30419 1/20 0.37
▸ CXCR4 P61073 2/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ CD274 Q9NZQ7 2/20 0.35
▸ PDCD1 Q15116 1/20 0.35
▸ CARM1 Q86X55 1/20 0.35
▸ PRMT6 Q96LA8 1/20 0.35
▸ NUDT1 P36639 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30040734 1.00 PTPN11 (0.45) PTPN11KCNH2EGFRSUV39H2ACHE
SCHEMBL24034170 0.87 PTPN11 (0.46) PTPN11KCNH2EGFRPRMT6
SCHEMBL30039350 0.87 PTPN11 (0.46) PTPN11KCNH2EGFRPRMT6
SCHEMBL24033828 0.83 PTPN11 (0.50) PTPN11KCNH2EGFRNUDT1
SCHEMBL24034250 0.75 PTPN11 (0.53) PTPN11KCNH2EGFR
SCHEMBL30040174 0.75 PTPN11 (0.53) PTPN11KCNH2EGFR
SCHEMBL24033715 0.75 PTPN11 (0.48) PTPN11KCNH2EGFRALDH1A1NUDT1
SCHEMBL24033834 0.75 PTPN11 (0.48) PTPN11KCNH2EGFRNUDT1
SCHEMBL24033831 0.75 PTPN11 (0.48) PTPN11KCNH2EGFRALDH1A1NUDT1
SCHEMBL24033835 0.75 PTPN11 (0.48) PTPN11KCNH2EGFRALDH1A1NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115353509-B Nitrogen-containing heteroaromatic derivative regulator, preparation method and application thereof 江苏豪森药业集团有限公司 2024-04-12 — — CN disclosed
CN-115353509-A Aza-containing aromatic derivative regulator, preparation method and application thereof 江苏豪森药业集团有限公司 2022-11-18 — — CN disclosed
CN-111295374-B Aza-containing aromatic derivative regulator, preparation method and application thereof 江苏豪森药业集团有限公司 2022-11-04 — — CN disclosed
US-20210355105-A1 REGULATOR OF NITROGEN-CONTAINING HETEROAROMATIC DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2021-11-18 — — US disclosed
CN-111295374-A Aza-containing aromatic derivative regulator, preparation method and application thereof 江苏豪森药业集团有限公司 2020-06-16 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210355105-A1 REGULATOR OF NITROGEN-CONTAINING HETEROAROMATIC DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF PTPN11, PTPN1, PTPN7 PTPN11 1/4885KCNH2 4613/4885EGFR 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback